Connective Tissue Diseases Clinical Trial
Official title:
Phenotypic Features and Prognostic Value of Anti-Ro52 (TRIM-21) Antibodies in Connective Tissue Diseases
Anti-Ro52 autoantibodies can be detected in patients with several autoimmune diseases. Clinical significance of anti-Ro52 is controversial. The presence of anti-Ro52 may be a factor associated with disease severity (interstitial lung disease, vasculopathy) and cancers. The aim of this study is to assess interstitial lung disease and vasculopathy prevalence and severity, cancers occurence and others clinical features of connective tissue disease patients with anti-Ro52 autoantibodies.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 | |
| Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
| Active, not recruiting |
NCT03688191 -
Study of Sirolimus in CTD-TP in China
|
Phase 4 | |
| Completed |
NCT00004357 -
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
|
Phase 2 | |
| Recruiting |
NCT04918524 -
The Clinical Features and Pregnancy Outcomes of CTD Patients
|
||
| Recruiting |
NCT04993885 -
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
|
Phase 2 | |
| Not yet recruiting |
NCT05998759 -
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
|
Phase 2 | |
| Recruiting |
NCT05065814 -
Connective Tissue Diseases and Vitamin D Deficiency
|
N/A | |
| Completed |
NCT03494036 -
Effect of Synbiotic on Immune Response, Gut Permeability and Microbiota in Patient With Connective Tissue Disease
|
N/A | |
| Completed |
NCT03929120 -
Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)
|
Phase 1 | |
| Completed |
NCT00001330 -
Study of Silicone-Associated Connective Tissue Diseases
|
N/A | |
| Not yet recruiting |
NCT05980728 -
Connective Tissue Disease Patients With Pulmonary Hypertension
|
||
| Not yet recruiting |
NCT04582292 -
Laryngeal Manifestations of Connective Tissue Diseases
|
||
| Completed |
NCT06458803 -
Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease
|
||
| Recruiting |
NCT03214263 -
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
|
||
| Completed |
NCT04171362 -
The Effect of Connective Tissue Massage in Patients With Migraine
|
N/A | |
| Completed |
NCT02392130 -
A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
|
Phase 1 | |
| Completed |
NCT01656278 -
An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis
|
N/A | |
| Recruiting |
NCT04915482 -
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05505409 -
Efficacy and Safety of Pirfenidone in CTD-ILD
|
Phase 4 |